Clinical trial
Open-Label Study of Aripiprazole in Individuals at Risk for Chronic Mental Illness
NCT00169949 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-Label Study of Aripiprazole in Individuals at Risk for Chronic Mental Illness
- Lead sponsor
- Northwell Health
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- January 31, 2004
- Completion date
- May 31, 2006
- Enrollment
- 30
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prodromal psychosis, prodromal schizophrenia